Immunic, Inc. - Common Stock (IMUX)

Immunic Inc is a biopharmaceutical company focused on developing innovative treatments for autoimmune and inflammatory diseases

The company is dedicated to advancing therapies that can address unmet medical needs, utilizing a proprietary drug development platform. Immunic is particularly engaged in researching and formulating oral medications that target specific pathways in immune response, with the aim of improving the quality of life for patients suffering from conditions such as multiple sclerosis, ulcerative colitis, and other chronic inflammatory disorders. Through its commitment to scientific excellence and clinical research, Immunic seeks to establish itself as a leader in the field of immunology.